In our study, impressively, adding anti-PD-1 antibodies to cocultures of lung cancer patients’ PBMCs with peptide-loaded PDC*line cells greatly favored the expansion (two-to-nine-fold increase) of tumor-specific T cells with different specificities in five out of eight patients tested. This evidence concerns the gene PDC and lung cancer.